Autobahn leads way to $76m series B

Jun 11, 2020 • Robert Lavine

OHSU's CNS disorder drug developer has launched with $76m from investors co-led by Arch Venture Partners and Cowen Healthcare Investments.

Autobahn Therapeutics, a US-based regenerative medicine spinout of Oregon Health and Science University (OHSU), closed a $76m series B round on Tuesday co-led by Arch Venture Partners and Cowen Healthcare Investments.
Pharmaceutical companies Biogen, Bristol Myers Squibb and Pfizer, the latter through its Pfizer Ventures subsidiary, took part in the round, as did BVF Partners, Invus, Section 32, Samsara BioCapital and Alexandria Venture Investments, the venture capital arm of real estate investment trust Alexandria Real Estate Equities.
Autobahn…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

2024 marks flurry of university spinout fund launches

University venture funds are becoming an increasingly important tool for universities to support their ecosystems — here are the new ones launched in 2024.

UK universities ready to pick up the pace of commercialisation in 2025

The UK stands to benefit from the work of the past 12 months to push more university research-led innovation into the marketplace.

8 tips for investing in Japan’s university spinouts

Japan has a well-funded and vibrant market for deep tech companies spun out of its universities. Here are some of the quirks that foreign investors seeking to dip a toe into the sector should look out for.

Events

Webinar: Designing a winning CVC platform – Engagement, venture development, operations

Jan 15, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Apr 8 -
Apr 10, 2025
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

May 1 -
May 6, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.